All
Demand to be heard
Making sense of epidemiological studies: Living with knowledge or fear?
Diagnosing ovarian cancer: Silent or subtle?
Ovarian cancer advocates gather on the hill
Gilotrif approved as treatment for advanced lung cancers driven by EGFR mutation
Surrogacy: Becoming a parent after cancer
Lung cancer video touches on emotions and support
Do you talk to your doctor about cost of care?
Whose genome is it anyway?
Are you biased when it comes to lung cancer?
CURE magazine - week one
Know where your donations go
Median survival of one month – whoop de doo
That perfect smile
Many African-American Women with Breast Cancer Need Screening for Inherited Mutations
One in five African-American women with breast cancer may have an inherited mutation in a breast cancer susceptibility gene.
PD-1 Inhibitors are a game changer
From ASCO: Updates on the Afinitor BOLERO-3 study in breast cancer
From ASCO: Updates in HER2-positive breast cancers
Paging Dr. Goldfarb
Avastin fails to provide benefit for patients with newly diagnosed glioblastoma
Nexavar halts thyroid cancer progression for five months
Small gain in ocular melanoma equals big news
Happy cancer survivor day to you and you and you
Erbitux edges ahead of Avastin for newly diagnosed metastatic colorectal cancer
Let's talk about sex
ASCO: big meeting for cancer patients
FDA Approves Tafinlar and Mekinist for Skin Cancer
Tafinlar and Mekinist target a specific tumor mutation in patients with metastatic or unresectable melanoma, a type of skin cancer.
#BTSM: Brain tumor Twitter chat connects survivors and caregivers
From a breast cancer husband's perspective
Reintegrating into life post-craniotomy
